MOREPENLAB - Morepen Laboratories

Morepen Laboratories

MOREPENLAB · Pharma > Pharmaceuticals & Drugs · Chairman: Sushil Suri · MD: Sushil Suri · Listing date: May 10, 1995 · Employees: 1510 · New Delhi · http://www.morepen.com

Stock Price vs Company Growth

2.3%

2.7%

4.0%

32.2%

63.3%

3.5%

3.6%

10y

8.9%

all

7.3%

🤔 How to analyze this graph?

Last Traded Price

₹ 55.3 2.3%

39.9

64.6

Company Overview

Sales

1,806 Cr

Growth: 2.3%

Profit after Tax

69.1 Cr

Growth: -6.2%

Small Cap

3,030 Cr

P/E: 32.0x

Industry P/E: 32.3x

Fundamentals

Sales (Cr)	₹ 1,806
Growth	2.3%
EBITDA	7.0%
P/S	1.7x
Dividend	0.4%
P/E	32.0x
Book Value	₹ 22.7
PEG Ratio	13.9x
ROE	5.7%
P/B	2.5x

Shareholding Pattern

Institutions

Pinfold Overseas Limited

8.57 %

Ferry Holdings Limited

4.45 %

Damodar Prasad Agarwal

1.63 %

Morepen Laboratories Limited

1.25 %

Promoters

Scope Credits & Financial Services Pvt. Ltd.

2.68 %

Concept Credits & Consultants Pvt. Ltd.

2.63 %

Brook Investments & Financial Services Pvt. Ltd.

2.59 %

Solitary Investments & Financial Services Pvt. Ltd

2.58 %

Solace Investments & Financial Services Pvt. Ltd.

2.57 %

Others

Increase Decrease No change

Company Profile Detailed

Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders.Morepen has steadily grown from a single product company to a multi activity company with a global vision and satisfied customers in over 50 countries.

Belongs to (9 Indices) view more

Investors (84)

shalu.su...

varun.su...

sanjay.s...

Followers (12)

sunil9

sudheer....

putta